Literature DB >> 8464093

Intestinal permeability is increased after major vascular surgery.

R M Roumen1, J A van der Vliet, R A Wevers, R J Goris.   

Abstract

PURPOSE: In experimental animals increased intestinal permeability has been demonstrated after ischemia and reperfusion injury. In this study we determined intestinal permeability in patients after elective or emergency aortic aneurysm repair; the latter patients were in severe shock on hospital admission.
METHODS: A dual sugar absorption test, with lactulose and mannitol as markers, was used to measure intestinal permeability on the second day between 24 and 30 hours after hospital admission.
RESULTS: The lactulose/mannitol excretion ration was 0.012 +/- 0.005 in seven healthy control subjects, 0.118 +/- 0.116 in seven patients having elective operation, and 0.098 +/- 0.093 in eight patients having emergency operation, indicating a significant increase of intestinal permeability in both patient groups (p < 0.01). No significant difference was found in intestinal permeability between patients of the elective and emergency groups.
CONCLUSIONS: A significant increase in intestinal permeability commonly occurs in patients after elective and emergency major vascular surgery. It is suggested that this is mainly due to reperfusion injury rather than the ischemic period of the intestine itself.

Entities:  

Mesh:

Year:  1993        PMID: 8464093     DOI: 10.1067/mva.1993.41204

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  12 in total

1.  Intestinal permeability in adult patients with growth hormone deficiency.

Authors:  J García-Arnés; C Sierra; F Tinahones; A Monzón; M J López; N Mazuecos; F Soriguer; E Valverde
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

2.  Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery.

Authors:  S Kanwar; A C Windsor; F Welsh; G R Barclay; P J Guillou; J V Reynolds
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9.

Authors:  Karina Zitta; Patrick Meybohm; Berthold Bein; Christin Heinrich; Jochen Renner; Jochen Cremer; Markus Steinfath; Jens Scholz; Martin Albrecht
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 4.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

5.  Randomised trial of safety and efficacy of immediate postoperative enteral feeding in patients undergoing gastrointestinal resection.

Authors:  C S Carr; K D Ling; P Boulos; M Singer
Journal:  BMJ       Date:  1996-04-06

Review 6.  Intestinal permeability, leaky gut, and intestinal disorders.

Authors:  D Hollander
Journal:  Curr Gastroenterol Rep       Date:  1999-10

7.  Increased intestinal permeability in rats with graft versus host disease.

Authors:  W A Koltun; M M Bloomer; P Colony; G L Kauffman
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

8.  Pancreatic duct ligation reduces lung injury following trauma and hemorrhagic shock.

Authors:  David B Cohen; Louis J Magnotti; Qi Lu; Da Zhong Xu; Tamara L Berezina; Sergey B Zaets; Carlos Alvarez; George Machiedo; Edwin A Deitch
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

9.  Antioxidative vitamin treatment: effect on lipid peroxidation and limb swelling after revascularization operations.

Authors:  H Rabl; G Khoschsorur; W Petek
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

Review 10.  Effects of surgery on the pharmacokinetic parameters of drugs.

Authors:  J M Kennedy; A M Riji
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.